Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease
Authors:
- 22 June 2011
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 34 (5) , 497-508
Abstract
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease strongly associated with inflammatory bowel disease (IBD). IBD patients diagnosed with PSC have an increased risk of colorectal dysplasia and cancer. To review the available evidence regarding colorectal neoplasia epidemiology, preventive strategies and outcomes in patients with PSC and IBD, and to advance some hypotheses regarding possible mechanisms involved in cancer pathogenesis in these patients. A PubMed search was conducted for the English language publications with predetermined search criteria. Reference lists from studies selected were manually searched to identify further relevant reports. Relevant manuscripts considering colorectal neoplasia in patients with PSC-IBD were selected. Primary sclerosing cholangitis increases the risk of colorectal neoplasia in patients with ulcerative colitis; fewer data are available for Crohn's disease. PSC-IBD patients tend to be younger at diagnosis of IBD and at diagnosis of colorectal cancer. Colorectal cancer in PSC-IBD patients predominates in the right colon. The increased risk of neoplasia is maintained after liver transplant and proctocolectomy. The role of ursodeoxycholic acid as a chemopreventive agent is controversial. The mechanisms underlying increased risk of colorectal neoplasia in these patients remain unknown. A more comprehensive understanding of the mechanisms involved in colorectal neoplasia development in PSC-IBD patients is needed. Until then, early cancer detection through enrolment in surveillance programmes is the only available strategy to decrease cancer risk.Keywords
This publication has 100 references indexed in Scilit:
- Incidence of primary sclerosing cholangitis: A systematic review and meta-analysisHepatology, 2011
- Carcinogenicity of deoxycholate, a secondary bile acidArchives of Toxicology, 2011
- Human intestinal microbiota: cross-talk with the host and its potential role in colorectal cancerCritical Reviews in Microbiology, 2010
- Bile acids: regulation of synthesisJournal of Lipid Research, 2009
- High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis #Hepatology, 2009
- A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responsesNature Medicine, 2009
- Modulation of the Intestinal Microbiota Alters Colitis-Associated Colorectal Cancer SusceptibilityPLOS ONE, 2009
- Induction of Persistent Colitis by a Human Commensal, EnterotoxigenicBacteroides fragilis, in Wild-Type C57BL/6 MiceInfection and Immunity, 2009
- Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasisCell Metabolism, 2005
- Role of bile acids in colorectal carcinogenesisEuropean Journal of Cancer, 1995